Search Results

Your search for Guido Marcucci, MD, and Clara D. Bloomfield, MD matches 2 pages

Showing 1 - 2

By Guido Marcucci, MD, and Clara D. Bloomfield, MD / July 10, 2013

Molecular Landscaping of Acute Myeloid Leukemia: Are We Relearning the Past or Informing the Future?

Acute myeloid leukemia (AML) is a clinically and molecularly heterogeneous disease.1 This concept has been supported by more than 4 decades of studies showing distinct outcomes of subsets of patients that differ in age, disease type (primary vs secondary vs therapy-related), and cytogenetic and...

issues in oncology

leukemia

By The ASCO Post Staff / Wednesday, May 15, 2013 5:39 PM

Study Identifies Possible New Treatment Target for Acute Leukemia

A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with cytogenetically normal acute myeloid leukemia (AML). The study was led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital...

Nov

Today In Oncology

Search Results

Your search for Guido Marcucci, MD, and Clara D. Bloomfield, MD matches 2 pages

Molecular Landscaping of Acute Myeloid Leukemia: Are We Relearning the Past or Informing the Future?

Study Identifies Possible New Treatment Target for Acute Leukemia

Addition of Hyperthermic Intraperitoneal Chemotherapy to Surgery for Recurrent Ovarian Cancer

Penpulimab Combination Therapy for First-Line Treatment of Hepatocellular Carcinoma

Global Adaptive Platform Trial for Glioblastoma to Evaluate Novel ATM Kinase Inhibitor

Healthy Women May Have Aneuploid Epithelial Cells Resembling Breast Cancer

Perioperative Toripalimab in Locoregionally Advanced Nasopharyngeal Carcinoma